Lung cancer trials in Hungary
57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Budapest XII, Gyongyos
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00 - Phase 2Taking peopleStudy of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE)
- Where
- Budapest XII, Szolnok
- Age
- 18 years to 64 years
- People
- 69 worldwide
- Run by
- Innate Pharma
See details and how to join2023-507778-42-00 · EU 2023-507778-42-00 - Phase 2Taking peopleIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
- Where
- Budapest, Farkasgyepű, Győr, Szolnok, Törökbálint
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Innate Pharma
See details and how to joinNCT05742607 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Budapest VIII, Budapest XII
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 4Taking peopleBudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onco-cardiology
- Where
- Budapest VIII
- Age
- 18 years and over
- People
- 1,000
- Run by
- Semmelweis University
See details and how to join2025-523620-44-02 · EU 2025-523620-44-02 - Phase 3Taking peopleA Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
- Where
- Budapest VIII, Budapest XII, Gyöngyös, Kecskemét, Szolnok, Törökbálint
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Maia Biotechnology
See details and how to joinNCT06908304 · EU 2024-520164-33-00 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Budapest XII, Tatabánya
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00